These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16407686)

  • 1. Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost.
    Osher E; Greenman Y; Tordjman K; Kisch E; Shenkerman G; Koffler M; Shapira I; Stern N
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1):29-34. PubMed ID: 16407686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"?
    Osher E; Stern N
    Diabetes Care; 2008 Feb; 31 Suppl 2():S249-54. PubMed ID: 18227493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
    Banegas JR; Segura J; Ruilope LM; Luque M; García-Robles R; Campo C; Rodríguez-Artalejo F; Tamargo J;
    Hypertension; 2004 Jun; 43(6):1338-44. PubMed ID: 15117908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group.
    Puig JG; Ruilope LM; Ortega R
    Hypertension; 1995 Dec; 26(6 Pt 2):1093-9. PubMed ID: 7498975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.
    Lloyd-Jones DM; Evans JC; Larson MG; O'Donnell CJ; Roccella EJ; Levy D
    Hypertension; 2000 Oct; 36(4):594-9. PubMed ID: 11040241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
    Cushman WC; Materson BJ; Williams DW; Reda DJ
    Hypertension; 2001 Oct; 38(4):953-7. PubMed ID: 11641316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study.
    Vamos EP; Harris M; Millett C; Pape UJ; Khunti K; Curcin V; Molokhia M; Majeed A
    BMJ; 2012 Aug; 345():e5567. PubMed ID: 22936794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Vidal-Petiot E; Ford I; Greenlaw N; Ferrari R; Fox KM; Tardif JC; Tendera M; Tavazzi L; Bhatt DL; Steg PG;
    Lancet; 2016 Oct; 388(10056):2142-2152. PubMed ID: 27590221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
    Neutel JM; Weber MA; Julius S; Cohn JN; Turlapaty P; Shen Y; Guo W; Batchelor A; Lagast H
    Am J Cardiovasc Drugs; 2004; 4(5):335-41. PubMed ID: 15449975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy.
    Agarwal R; Weir MR
    J Am Soc Hypertens; 2013; 7(3):236-43. PubMed ID: 23523137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F; Bramlage P; Paar WD
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
    Verdecchia P; Staessen JA; Angeli F; de Simone G; Achilli A; Ganau A; Mureddu G; Pede S; Maggioni AP; Lucci D; Reboldi G;
    Lancet; 2009 Aug; 374(9689):525-33. PubMed ID: 19683638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.
    Weber MA; Bloch M; Bakris GL; Weir MR; Zappe DH; Dahlof B; Velazquez EJ; Pitt B; Basile JN; Jamerson K; Hua TA
    J Clin Hypertens (Greenwich); 2016 Apr; 18(4):299-307. PubMed ID: 27060568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
    Spoelstra-de Man AM; van Ittersum FJ; Schram MT; Kamp O; van Dijk RA; Ijzerman RG; Twisk JW; Brouwer CB; Stehouwer CD
    J Hum Hypertens; 2006 Aug; 20(8):599-611. PubMed ID: 16673014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.